Alphelix Biosciences is a biotechnology company focused on the early discovery of membrane protein drugs. Through several world leading membrane protein technology platforms with proprietary intellectual property, we provide global innovative pharmaceutical companies with one-stop services ranging from membrane protein target preparation and structural determination to the early discovery of antibodies, small molecules, and peptide drugs.

Our Services:

Unique Advantages:

It is well known that obtaining ligand-free, biologically active, high-purity GPCR proteins from extracellular sources poses a significant challenge in the scientific community. However, utilizing our proprietary MegaR technology platform allows for the efficient acquisition of these proteins, such as GPR75, CCR8, and VIP2R. These proteins are highly suitable for DEL screening, AS-MS screening, antibody discovery/screening, and ligand affinity measurement.

Our Technology Platform：